Significance of CD90+ Cancer Stem Cells in Human Liver Cancer

Cancer Cell

Volumn 13, Issue 2, 2008, Pages 153-166

  Yang, Zhen Fan ^a   Ho, David W ^a   Ng, Michael N ^a   Lau, Chi Keung ^a   Yu, Wan Ching ^a   Ngai, Patricia ^a   Chu, Patrick W K ^a   Lam, Chi Tat ^a   Poon, Ronnie T P ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER PATIENT; CANCER STEM CELL; CARCINOGENIC ACTIVITY; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MUS;

EID: 38549139140     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.01.013     Document Type: Article

References (54)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
2. Alison M.R. Liver cancer: A disease of stem cells?. Panminerva Med. 48 (2006) 165-174
3. Arii S., Yamaoka Y., Futagawa S., Inoue K., Kobayashi K., Kojiro M., Makuuchi M., Nakamura Y., Okita K., and Yamada R. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32 (2000) 1224-1229
4. Brown J.J., Parashar B., Moshage H., Tanaka K.E., Engelhardt D., Rabbani E., Roy-Chowdhury N., and Roy-Chowdhury J. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 31 (2000) 173-181
5. Bruggeman S.W., Hulsman D., Tanger E., Buckle T., Blom M., Zevenhoven J., van Tellingen O., and van Lohuizen M. Bmi1 controls tumor development in an ink4a/arf-independent manner in a mouse model for glioma. Cancer Cell 12 (2007) 328-341
6. Campbell P.A., Perez-Iratxeta C., Andrade-Navarro M.A., and Rudnicki M.A. Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE. 2 (2007) e553
7. Ceafalan L., Vidulescu C., Radu E., Regalia T., Popescu I., Pana M., Serghei L., Voiculescu B., and Popescu L.M. Expression of stem cell markers on fetal and tumoral human liver cells in primary culture. Rev. Med. Chir. Soc. Med. Nat. Iasi 109 (2005) 96-104
8. Chiba S. Notch signaling in stem cell systems. Stem Cells 24 (2006) 2437-2447
9. Cho R.W., Wang X., Diehn M., Shedden K., Chen G.Y., Sherlock G., Gurney A., Lewicki J., and Clarke M.F. Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1 Murine Breast Tumors. Stem Cells (2007) in press. Published online November 7, 2007
10. Colli A., Fraquelli M., Casazza G., Massironi S., Colucci A., Conte D., and Duca P. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am. J. Gastroenterol. 101 (2006) 513-523
11. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65 (2005) 10946-10951
12. Corcelle V., Stieger B., Gjinovci A., Wollheim C.B., and Gauthier B.R. Characterization of two distinct liver progenitor cell subpopulations of hematopoietic and hepatic origins. Exp. Cell Res. 312 (2006) 2826-2836
13. Curto M., and McClatchey A.I. Ezrin...a metastatic detERMinant?. Cancer Cell 5 (2004) 113-114
14. Dan Y.Y., Riehle K.J., Lazaro C., Teoh N., Haque J., Campbell J.S., and Fausto N. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc. Natl. Acad. Sci. USA 103 (2006) 9912-9917
15. Dennis J.E., Esterly K., Awadallah A., Parrish C.R., Poynter G.M., and Goltry K.L. Clinical-scale Expansion of a Mixed Population of Bone Marrow Derived Stem and Progenitor Cells for Potential Use in Bone Tissue Regeneration. Stem Cells 25 (2007) 2575-2582
16. El-Serag H.B. Hepatocellular carcinoma: Recent trend in the United States. Gastroenterology 127 (2004) S27-S34
17. Fiegel H.C., Park J.J., Lioznov M.V., Martin A., Jaeschke-Melli S., Kaufmann P.M., Fehse B., Zander A.R., and Kluth D. Characterization of cell types during rat liver development. Hepatology 37 (2003) 148-154
18. Gilbertson R.J., and Rich J.N. Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 7 (2007) 733-736
19. Götte M., and Yip G.W. Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res. 66 (2006) 10233-10237
20. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N. Engl. J. Med. 332 (1995) 1256-1261
21. Herrera M.B., Bruno S., Buttiglieri S., Tetta C., Gatti S., Deregibus M.C., Bussolati B., and Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24 (2006) 2840-2850
22. Ho J.W., Pang R.W., Lau C., Sun C.K., Yu W.C., Fan S.T., and Poon R.T. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 44 (2006) 836-843
23. Isabel Z., Miri B., Einav H., Ella B.L., Zamir H., and Ran O. Isolation, characterization and culture of Thy1-positive cells from fetal rat livers. World J. Gastroenterol. 12 (2006) 3841-3847
24. Jochum W., Passegué E., and Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene 20 (2001) 2401-2412
25. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
26. Kim D.J., Chan K.S., Sano S., and Digiovanni J. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol. Carcinog. 46 (2007) 725-731
27. Lara-Pezzi E., Serrador J.M., Montoya M.C., Zamora D., Yanez-Mo M., Carretero M., Furthmayr H., Sanchez-Madrid F., and Lopez-Cabrera M. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: Possible role of HBx in invasion and metastasis. Hepatology 33 (2001) 1270-1281
28. Lázaro C.A., Croager E.J., Mitchell C., Campbell J.S., Yu C., Foraker J., Rhim J.A., Yeoh G.C., and Fausto N. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38 (2003) 1095-1106
29. Lee H.C., Kim M., and Wands J.R. Wnt/Frizzled signaling in hepatocellular carcinoma. Front. Biosci. 11 (2006) 1901-1915
30. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030-1037
31. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., and Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5 (2006) 67
32. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 30 (1999) 1434-1440
33. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
34. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T., Fan S.T., and Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
35. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., and Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132 (2007) 2542-2556
36. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., and Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334 (1996) 693-699
37. McMahon B.J. Epidemiology and natural history of hepatitis B. Semin. Liver Dis. 25 Suppl 1 (2005) 3-8
38. Minervini M.I., Demetris A.J., Lee R.G., Carr B.I., Madariaga J., and Nalesnik M.A. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod. Pathol. 10 (1997) 686-692
39. Nava S., Westgren M., Jaksch M., Tibell A., Broome U., Ericzon B.G., and Sumitran-Holgersson S. Characterization of cells in the developing human liver. Differentiation 73 (2005) 249-260
40. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
41. Pang R.W., Lee T.K., Man K., Poon R.T., Fan S.T., Kwong Y.L., and Tse E. PIN1 expression contributes to hepatic carcinogenesis. J. Pathol. 210 (2006) 19-25
42. Paul S.A., Simons J.W., and Mabjeesh N.J. HIF at the crossroads between ischemia and carcinogenesis. J. Cell. Physiol. 200 (2004) 20-30
43. Rege T.A., and Hagood J.S. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20 (2006) 1045-1054
44. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
45. Seiki M. Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion. Cancer Lett. 194 (2003) 1-11
46. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
47. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., and Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 351 (2006) 820-824
48. Tang C., Ang B.T., and Pervaiz S. Cancer stem cell: Target for anti-cancer therapy. FASEB J. 21 (2007) 3777-3785
49. Tang Z.Y., Ye S.L., Liu Y.K., Qin L.X., Sun H.C., Ye Q.H., Wang L., Zhou J., Qiu S.J., Li Y., et al. A decade's studies on metastasis of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130 (2004) 187-196
50. Tian J., Tang Z.Y., Ye S.L., Liu Y.K., Lin Z.Y., Chen J., and Xue Q. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br. J. Cancer 81 (1999) 814-821
51. Yang Z.F., Poon R.T., To J., Ho D.W., and Fan S.T. The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma. Cancer Res. 64 (2004) 5496-5503
52. Yang Z.F., Poon R.T., Luo Y., Cheung C.K., Ho D.W., Lo C.M., and Fan S.T. Upregulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2 (Flk-1)-dependent pathway. J. Immunol. 173 (2004) 2507-2515
53. Yang Z.F., Ho D.W., Lam C.T., Luk J.M., Lum C.T., Yu W.C., Poon R.T., and Fan S.T. Identification of brain-derived neurotrophic factor (BDNF) as a novel functional protein in hepatocellular carcinoma. Cancer Res. 65 (2005) 219-225
54. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., Jiang G., Ge C., Xie H., Wan D., et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120 (2007) 1436-1442